Crucible Therapeutics is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Based in the United Kingdom, Crucible Therapeutics is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Crucible Therapeutics is a UK-based biotechnology company developing novel RNA-targeting therapies to treat neurodegenerative diseases, specifically Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.